IS5235A - N-tríazólýl-2-indólkarboxamíð og notkun þeirra sem gallblöðruhreyfil-A gerandefni - Google Patents

N-tríazólýl-2-indólkarboxamíð og notkun þeirra sem gallblöðruhreyfil-A gerandefni

Info

Publication number
IS5235A
IS5235A IS5235A IS5235A IS5235A IS 5235 A IS5235 A IS 5235A IS 5235 A IS5235 A IS 5235A IS 5235 A IS5235 A IS 5235A IS 5235 A IS5235 A IS 5235A
Authority
IS
Iceland
Prior art keywords
indolecarboxamide
gallbladder
triazolyl
agonist
engine
Prior art date
Application number
IS5235A
Other languages
English (en)
Inventor
Bignon Eric
Pierre Bras Jean
De Cointet Paul
Despeyroux Pierre
Frehel Daniel
Gully Danielle
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of IS5235A publication Critical patent/IS5235A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IS5235A 1997-05-13 1999-10-29 N-tríazólýl-2-indólkarboxamíð og notkun þeirra sem gallblöðruhreyfil-A gerandefni IS5235A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1998/000905 WO1998051686A1 (fr) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a

Publications (1)

Publication Number Publication Date
IS5235A true IS5235A (is) 1999-10-29

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5235A IS5235A (is) 1997-05-13 1999-10-29 N-tríazólýl-2-indólkarboxamíð og notkun þeirra sem gallblöðruhreyfil-A gerandefni

Country Status (35)

Country Link
EP (1) EP0984960B1 (is)
JP (1) JP2001524980A (is)
KR (1) KR20010012541A (is)
CN (1) CN1263528A (is)
AR (1) AR011729A1 (is)
AT (1) ATE232207T1 (is)
AU (1) AU725530B2 (is)
BR (1) BR9811465A (is)
CA (1) CA2289573A1 (is)
CO (1) CO4940485A1 (is)
CZ (1) CZ289484B6 (is)
DE (1) DE69811223T2 (is)
DK (1) DK0984960T3 (is)
DZ (1) DZ2486A1 (is)
EE (1) EE9900524A (is)
ES (1) ES2190081T3 (is)
FR (1) FR2763337B1 (is)
GT (1) GT199800068A (is)
HR (1) HRP980258B1 (is)
HU (1) HUP0002763A3 (is)
ID (1) ID22911A (is)
IL (1) IL132903A0 (is)
IS (1) IS5235A (is)
NO (1) NO995513L (is)
NZ (1) NZ500637A (is)
PL (1) PL336772A1 (is)
RU (1) RU2175323C2 (is)
SI (1) SI0984960T1 (is)
SK (1) SK154299A3 (is)
TR (1) TR199902795T2 (is)
TW (1) TW396155B (is)
UY (1) UY24997A1 (is)
WO (1) WO1998051686A1 (is)
YU (1) YU57999A (is)
ZA (1) ZA983997B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
BR0114888A (pt) * 2000-10-26 2003-12-09 Sanofi Synthelabo Derivados de triazol e composições farmacêuticas compreendendo os mesmos
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
CA2463441A1 (en) * 2001-10-12 2003-05-08 Bayer Pharmaceuticals Corporation Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (en) 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
ES2293005T3 (es) * 2002-10-03 2008-03-16 F. Hoffmann-La Roche Ag Indol-3-carboxamidas como activadores de la glucocinasa.
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
EP1532980A1 (en) * 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
RU2415134C9 (ru) * 2005-08-15 2011-05-27 Этерна Центарис ГмбХ Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе
WO2008091631A1 (en) 2007-01-26 2008-07-31 Merck & Co., Inc. Substituted aminopyrimidines as cholecystokinin-1 receptor modulators
EP2349484A2 (en) 2008-07-15 2011-08-03 Novartis AG Heteroaryl derivatives as dgat1 inhibitors
NZ597453A (en) * 2009-06-09 2013-03-28 Actelion Pharmaceuticals Ltd Fluorinated aminotriazole derivatives as alxr agonists
EP2490656B1 (de) * 2009-10-22 2017-01-18 Henkel AG & Co. KGaA Mittel zur behandlung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein anionisches polymer
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
MX2022010548A (es) 2020-02-28 2022-09-23 Kallyope Inc Agonistas de gpr40.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
WO1998051686A1 (fr) 1998-11-19
NO995513D0 (no) 1999-11-11
CZ289484B6 (cs) 2002-01-16
FR2763337B1 (fr) 1999-08-20
NZ500637A (en) 2000-11-24
CZ400699A3 (cs) 2000-02-16
EP0984960A1 (fr) 2000-03-15
YU57999A (sh) 2002-06-19
AU725530B2 (en) 2000-10-12
HUP0002763A3 (en) 2002-05-28
KR20010012541A (ko) 2001-02-15
IL132903A0 (en) 2001-03-19
EE9900524A (et) 2000-06-15
ES2190081T3 (es) 2003-07-16
SI0984960T1 (en) 2003-06-30
UY24997A1 (es) 2000-10-31
HUP0002763A2 (hu) 2001-06-28
FR2763337A1 (fr) 1998-11-20
TW396155B (en) 2000-07-01
DZ2486A1 (fr) 2003-02-01
TR199902795T2 (xx) 2000-02-21
EP0984960B1 (fr) 2003-02-05
SK154299A3 (en) 2000-05-16
ID22911A (id) 1999-12-16
AR011729A1 (es) 2000-08-30
HRP980258A2 (en) 1999-02-28
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
ZA983997B (en) 1999-11-12
PL336772A1 (en) 2000-07-17
DE69811223T2 (de) 2003-11-27
GT199800068A (es) 1999-11-11
RU2175323C2 (ru) 2001-10-27
CN1263528A (zh) 2000-08-16
NO995513L (no) 2000-01-12
JP2001524980A (ja) 2001-12-04
ATE232207T1 (de) 2003-02-15
DE69811223D1 (de) 2003-03-13
BR9811465A (pt) 2000-09-12
DK0984960T3 (da) 2003-05-26
CO4940485A1 (es) 2000-07-24
HRP980258B1 (en) 2002-08-31

Similar Documents

Publication Publication Date Title
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID20143A (id) Peralatan akustik
NO20032753D0 (no) Forbindelse og anvendelse derav
DK1051325T3 (da) LNG-lastoverförselssystem
NO975894L (no) Foringsr°rpakning
DK57996A (da) Lyddæmper
NO984316D0 (no) Skjµreverkt°y
NO983462D0 (no) Isoleringsverkt°y
NO985766L (no) B°lgeenergiomformer
DE69821569D1 (de) Tetraederinterpolation
ATA101594A (de) Ringbuchmechanik
NO990552D0 (no) Innrettingsverkt°y
ID20285A (id) Katrol tangan
ID24431A (id) Lateks-lateks yang tahan gosokan
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO992852D0 (no) Basisstr°mningsenhet
NO992357L (no) B°yekonstruksjon
DE59911758D1 (de) Würfel
KR970057191U (ko) 수동식 드라이버
KR970050889U (ko) 오징어 구이기
FR2754560B1 (fr) Persienne
KR970053579U (ko) 아령
KR980000222U (ko) 브레지어
ID16772A (id) Tongkang
LV11597A (lv) Kajritenis